A Study of TQ05105 in Patients With Chronic Graft Versus Host Disease

NCT04944043 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

45

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Graft Versus Host Disease

Interventions

DRUG: TQ05105 Tablet

Sponsor

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.